Moderna recently announced an important breakthrough in the development of new coronavirus vaccine, with a clinical effective rate of 94.5%. A few days ago, the CEO of the company announced the charging standard. According to the order quantity, the company will charge 25-37 US dollars, about 164 to 243 yuan, which is not too expensive.
Moderna company is one of the important new crown virus vaccine research and development units in the United States, taking the mRNA route. As soon as Chinese scientists announced the virus sequence early this year, their vaccine research and development started, so the progress is also relatively fast.
According to the previously published clinical phase III test data,The candidate vaccine mrna-1273 has reached the statistical efficacy standard specified in the study protocol, and the efficacy has reached 94.5%.
In terms of safety, the mrna-12733 vaccine did not report any major safety risks. The vaccine was well tolerated, and most of the adverse events were mild or moderate, and the duration was short.
Because the vaccine is also a mRNA technology, many people worry that its storage conditions are as harsh as Pfizer's mRNA vaccine, requiring a temperature of - 75 degrees below zero. However, Moderna said its vaccine was stable,It can keep stable in 2-8 ℃ for 30 daysThe Pfizer vaccine can last only five days in the same situation.
Moderna company's vaccine development is almost over, the rest is mainly listed approval and pricing issues, they are currently negotiating procurement with the European Union, Moderna the company CEO Stephane Bancel said that no agreement has been signed, but we are about to reach an agreement with the European Commission. We hope to deliver to Europe and are engaged in constructive negotiations. The contract is only a matter of days.
As for the price, Stephane Bancel said,The company will charge governments $25-37, or 164 to 243 yuan, depending on the number of orders.
But the European Union hopes to reach an agreement with Moderna to craft millions of vaccines at less than $25.
- THE END -
Reprint please indicate the source: fast technology